An interventional study of Integrated Treatment for PTSD and Chronic Pain in PTSD and Chronic Pain, sponsored by Weill Medical College of Cornell University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-15.
Sponsored by Weill Medical College of Cornell University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 14 studies in Stress Disorders, Post-Traumatic by Weill Medical College of Cornell University — 4 open to participants now, 4 under way, none of them phase 3. Stress Disorders, Post-Traumatic · Weill Medical College of Cornell University.
Among the 14 studies in Stress Disorders, Post-Traumatic by Weill Medical College of Cornell University, this one is the 8th largest by planned enrollment of the 12 interventional ones that give a count, is the only one that started in 2025, is one of 7 with no phase, and was the 14th registered.
2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.
Browse Stress Disorders, Post-Traumatic studies →4 of the 14 studies in Stress Disorders, Post-Traumatic by Weill Medical College of Cornell University are open now, in 1 country. Recruiting first, the newest first:
Weill Medical College of Cornell University · Sites in United States
Ages 18+
Weill Medical College of Cornell University · Sites in United States
Ages 18+ · Healthy volunteers
Weill Medical College of Cornell University · Sites in United States
Ages 18–85
By country, each count listing its studies:
Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
14 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 1 · Phase 3 1 · Phase 4 1
First in 2003; this study’s year is marked. 1 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 69 across 2,203 interventional studies indexed under Stress Disorders, Post-Traumatic.
Median enrollment 23 across the 12 interventional studies, 63 across the 2 observational. Of the 10 that completed or were terminated, 4 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
Weill Medical College of Cornell University is the lead sponsor of 893 studies on the registry; 165 are open to participants now.
Of its 124 completed or terminated interventional studies of FDA-regulated products, 95 (77%) have results posted.
3 of the studies in Stress Disorders, Post-Traumatic by Weill Medical College of Cornell University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04887116Weill Medical College of Cornell UniversityPiloting Virtual Reality Environments to Treat PTSD in Healthcare Workers | 2027-01 |
| NCT03803332Weill Medical College of Cornell UniversityA Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel | 2027-03 |
| NCT07225049Weill Medical College of Cornell UniversityIntegrated PTSD and Chronic Pain Treatment | 2027-08 |
Add all 3 to your calendar (.ics) → With an account.
Among the 14 studies in Stress Disorders, Post-Traumatic by Weill Medical College of Cornell University, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Posttraumatic stress disorder (PTSD) occurs in approximately 7% of adults in the general population. PTSD greatly impacts quality of life and often co-occurs with other conditions such as chronic pain. Individuals with co-morbid PTSD and chronic pain demonstrate higher PTSD symptoms and pain (as well as greater anxiety, depression, disability, and opioid use) compared to those with only one of those conditions. Gold standard treatments exist for both PTSD (e.g., Prolonged Exposure; PE) and chronic pain (e.g., Cognitive Behavioral Therapy for Chronic Pain; CBT-CP) and are generally offered sequentially (i.e., one at a time for the condition that is most prominent). Treating these conditions separately may overlook their interconnected nature, which may reduce efficacy and increase dropout. Thus, there is a need for an intervention to target both simultaneously, which may be more effective and efficient than treating conditions sequentially.
This is a single-arm pilot study to assess the feasibility and acceptability of an integrated treatment for adults with comorbid PTSD and chronic pain. The intervention consists of 12 90-minute virtual psychotherapy sessions scheduled twice per week. The treatment draws from modules in PE and CBT-CP including psychoeducation, exposure to feared/avoided situations and activities, processing of exposures, behavioral activation, breathing and relaxation techniques, sleep hygiene, symptom monitoring, and structured homework assignments. Baseline and post-treatment assessments will be conducted.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Integrated treatment combining modules from Prolonged Exposure Therapy with Cognitive Behavioral Therapy for Chronic Pain
Behavioral: Integrated Treatment for PTSD and Chronic Pain
The intervention consists of 12 90-minute virtual psychotherapy sessions scheduled twice per week. The treatment integrates modules from Prolonged Exposure and Cognitive Behavioral Therapy for Chronic Pain.
Feasibility Indicator: Number of Participants Screened
Feasibility assessment will include number of participants screened defined as number of individuals who complete our initial eligibility screener.
Time frame: Baseline
Feasibility Indicator: Enrollment
Feasibility assessment will include enrollment defined as number of participants signing the informed consent form.
Time frame: Baseline
Feasibility Indicator: Number of Sessions Attended
Feasibility assessment will include the number of sessions attended on average (out of 12).
Time frame: Post-Treatment Assessment at approximately 6 weeks
Feasibility Indicator: Attrition Percentage
A feasibility measure of attrition will be assessed by examining the percent of individuals who did not complete all 12 intervention sessions.
Time frame: Post-Treatment Assessment at approximately 6 weeks
Feasibility Indicator: Number of Assessments Attended
A feasibility indicator of number of assessments (baseline and post-treatment) attended will be measured.
Time frame: Baseline and Post-Treatment Assessment at approximately 6 weeks
Feasibility Indicator: Percentage of Self-Reports Completed
Self-reports are administered at each assessment (baseline and post-intervention) as well as every other treatment session (every 2 weeks up to 12 weeks). Therefore, there are 8 total self-report assessments and the percentage of those completed will be calculated.
Time frame: Baseline, Post-Intervention at approximately 6 weeks, Every Other Treatment Session (Every 2 weeks up to 12 weeks)
Intervention Satisfaction
Intervention satisfaction will be rated with a Likert scale ranging from 1-10 with greater scores indicating higher satisfaction.
Time frame: Post-Treatment Assessment at approximately 6 weeks
Intervention Acceptability
Intervention acceptability will be measured on a Likert scale ranging from 1-10 with greater scores indicating higher acceptability.
Time frame: Post-Treatment Assessment at approximately 6 weeks
Qualitative Intervention Feedback
Open-ended questions that include assessing overall impressions of treatment, feedback on the frequency and length of sessions, challenges or barriers, likelihood of recommending this treatment to a friend, and comparison of this treatment to other treatments received in the past.
Time frame: Post-Treatment Assessment at approximately 6 weeks
Change in Score on the Clinician Administered PTSD Score (CAPS-5)
Change in Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) Score. Total Scores range from 0-80. Higher scores indicate greater symptom severity.
Time frame: Baseline to approximately 6 weeks
Change in Score on the PTSD Checklist for DSM-5 (PCL-5)
The well-validated PCL-5 will assess self-reported PTSD symptom severity. Scores range from 0-80. Higher scores indicate greater symptom severity.
Time frame: Baseline to approximately 6 weeks
Change in Score on the Pain Severity Subscale of the Brief Pain Inventory (BPI)
Pain severity is a 4-item subscale with ranges from 0-10. Greater scores indicate higher pain severity.
Time frame: Baseline to approximately 6 weeks
Change in Score on the Pain Interference Subscale of the Brief Pain Inventory (BPI)
Pain interference is a 7-item subscale with ranges from 0-10. Greater scores indicate greater pain interference.
Time frame: Baseline to approximately 6 weeks
Change in Score on the Pain Catastrophizing Scale (PCS)
The 13-item PCS measure has scores ranging from 0-52, with higher scores indicating greater pain catastrophizing. Three subscales (rumination, magnification, and helplessness) are summed to form the total score.
Time frame: Baseline to approximately 6 weeks
Change in Score on the Chronic Pain Acceptance Questionnaire (CPAQ)
This 20-item measure results in a total score ranging from 0-120 with high scores reflecting greater acceptance of pain. Two subscales (activity engagement and pain willingness) are summed to create the total score.
Time frame: Baseline to approximately 6 weeks
Change in Score on the Posttraumatic Cognitions Inventory (PTCI)
The 33-item PTCI yields three subscores: negative cognitions about the self, negative cognitions about the world, and self-blame. Items are averaged so the range of scores for each subscale is 0-7 with higher scores representing more maladaptive cognitions. A total score is calculated by summing each of the 33 items yielding a score between 33-231, with higher scores indicating more maladaptive cognitions.
Time frame: Baseline to approximately 6 weeks
Change in Score on the Fear-Avoidance Components Scale (FACS)
This 20-item measure results in total scores ranging from 0-100, with greater scores indicating more severe fear-avoidance beliefs.
Time frame: Baseline to approximately 6 weeks
Change in Score on the Anxiety Sensitivity Index (ASI-3)
This 18-item measure results in a total score ranging from 0-72 with higher scores reflecting greater anxiety sensitivity. Three subscales (physical concerns, cognitive concerns, and social concerns) are summed to create a total score.
Time frame: Baseline to approximately 6 weeks
Change in Score on the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST)
The ASSIST is a questionnaire that screens for all levels of problem or risky substance use in adults including tobacco, alcohol, cannabis, cocaine, amphetamine-type stimulants, inhalants, sedatives, hallucinogens, opioids, and other drugs. A score for each substance ranges from 0-39 with higher scores indicating greater problems or risks related to substance use. A total score is not computed and instead, each substance will be analyzed individually.
Time frame: Baseline to approximately 6 weeks
Change in Score on the Expectancies for Alcohol Analgesia (EAA) Measure
The EAA is a 5-item scale. Items are summed to generate a total score ranging from 0-45 with higher scores indicating greater expectancy for alcohol analgesia.
Time frame: Baseline to approximately 6 weeks
Change in Score on the Difficulties in Emotion Regulation Scale (DERS-18)
This 18-item measure results in a total score ranging from 18-90 with higher scores reflecting greater difficulties with emotion regulation.
Time frame: Baseline to approximately 6 weeks
Change in Score on the Patient Health Questionnaire (PHQ-9)
The PHQ-9 scores range from 0-27. Higher scores indicate greater symptom severity.
Time frame: Baseline to approximately 6 weeks
Change in Score on the Insomnia Severity Index (ISI)
7 item self-report measure. Total scores range from 0-28, with higher scores indicating higher insomnia severity.
Time frame: Baseline to approximately 6 weeks
Change in Score on the Multidimensional Assessment of Interoceptive Awareness (MAIA-2)
This is a 37-item measure that results in 8 subscales: noticing, not-distracting, not-worrying, attention regulation, emotional awareness, self-regulation, body listening, and trust. Each subscale ranges from 0-5, where higher scores reflect more awareness of bodily sensations. A total score is not computed, and instead, each subscale is analyzed individually.
Time frame: Baseline to approximately 6 weeks
Change in Score on the Quality of Life Inventory (QOLI)
The assessment yields an overall score and profile in 16 areas of life; health, self-esteem, goals and values, money, work, play, learning, creativity, helping, love, friends, children, relatives, home, neighborhood, and community. Subscales are computed by multiplying satisfaction (-3 to +3) by importance (0 to 2) and resulting scores are averaged to yield a total score ranging from -6 to +6, with higher scores indicate higher level of quality of life.
Time frame: Baseline to approximately 6 weeks
Change in Score on the Religious and Spiritual Struggles Scale (RSS-5)
This is a 5-item questionnaire measuring the extent to which one experiences conflict or struggle with spirituality or religious faith. Each item is rated on a scale from 1 (Not at All) to 5 (A Great Deal), thus higher scores indicate more spiritual struggle.
Time frame: Baseline to approximately 6 weeks
Plan to share: No
No publications or documents are linked to this record.
Started Dec 2025 (actual). Primary completion is estimated for Aug 2027, 20 months after the start.
Of 1,066 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 20 months is below that.
Counting every sponsor, half of 1,094 studies reached it within 35 months; a quarter within 17 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stress Disorders, Post-Traumatic →
Weill Medical College of Cornell University →